From the Department of Cardiology, Hospital Clinico Universitario, Valencia, Spain (M.I., J.M.S.-G., A.F.d.L.-O., A.M., J.N., C.N., J.C., R.R.-G.); Department of Cardiology, Hospital General, Castellón, Spain (A.B.); and Department of Cardiology, Hospital Doctor Peset, Valencia, Spain (A.P.).
Circ Arrhythm Electrophysiol. 2015 Aug;8(4):882-9. doi: 10.1161/CIRCEP.115.002827. Epub 2015 Jun 8.
Epicardial ablation has shown improvement in clinical outcomes of patients with ischemic heart disease (IHD) after ventricular tachycardia (VT) ablation. However, usually epicardial access is only performed when endocardial ablation has failed. Our aim was to compare the efficacy of endocardial+epicardial ablation versus only endocardial ablation in the first procedure in patients with IHD.
Fifty-three patients with IHD, referred for a first VT ablation to our institution, from 2012 to 2014, were included. They were divided in 2 groups according to enrollment time: from May 2013, we started to systematically perform endo-epicardial access (Epi-Group) as first-line approach in consecutive patients with IHD (n=15). Patients who underwent only an endocardial VT ablation in their first procedure (Endo-Group) included patients with previous cardiac surgery and the historical (before May 2013; n=35). All late-potentials in the scar zone were eliminated, and if VT was tolerated, critical isthmuses were also approached. The end point was the noninducibility of any VT. During a median follow-up of 15±10 months, the combined end point (hospital or emergency admission because of a ventricular tachycardia or reablation) occurred in 14 patients of the Endo-group and in one patient in the Epi-group (event-free survival curves by Grey-test, P=0.03). Ventricular arrhythmia recurrences occurred in 16 and in 3 patients in the Endo and Epi-Group, respectively (Grey-test, P=0.2).
A combined endocardial-epicardial ablation approach for initial VT ablation was associated with fewer readmissions for VT and repeat ablations. Further studies are warranted.
心外膜消融已显示出在室性心动过速(VT)消融后改善缺血性心脏病(IHD)患者的临床结果。然而,通常仅在心内膜消融失败时才进行心外膜入路。我们的目的是比较 IHD 患者首次手术中心内膜+心外膜消融与仅心内膜消融的疗效。
2012 年至 2014 年,我们机构收治了 53 例 IHD 患者,因 VT 消融而接受首次消融治疗。根据入组时间将他们分为两组:自 2013 年 5 月起,我们开始系统地进行心内膜-心外膜入路(Epi 组),对连续的 IHD 患者(n=15)作为一线治疗方法。仅行首次心内膜 VT 消融的患者(Endo 组)包括既往心脏手术患者和历史组(2013 年 5 月前,n=35)。所有瘢痕区的晚电位均被消除,如果 VT 可耐受,则也处理关键峡部。终点为任何 VT 均不可诱导。在 15±10 个月的中位随访期间,Endo 组中有 14 例患者和 Epi 组中有 1 例患者发生联合终点事件(因 VT 而住院或急诊入院或再次消融)(Grey 检验的无事件生存曲线,P=0.03)。Endo 和 Epi 组的心律失常复发分别为 16 例和 3 例(Grey 检验,P=0.2)。
初次 VT 消融时采用心内膜-心外膜联合消融方法与较少因 VT 而再次入院和重复消融相关。需要进一步的研究。